首页> 外文期刊>Radiology >Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)
【24h】

Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)

机译:骨髓瘤全身MRI的收购,解释和报告指南:骨髓瘤响应评估和诊断系统(MY-RAD)

获取原文
获取原文并翻译 | 示例
           

摘要

Acknowledging the increasingly important role of whole-body MRI for directing patient care in myeloma, a multidisciplinary, international, and expert panel of radiologists, medical physicists, and hematologists with specific expertise in whole-body MRI in myeloma convened to discuss the technical performance standards, merits, and limitations of currently available imaging methods. Following guidance from the International Myeloma Working Group and the National Institute for Clinical Excellence in the United Kingdom, the Myeloma Response Assessment and Diagnosis System (or MY-RADS) imaging recommendations are designed to promote standardization and diminish variations in the acquisition, interpretation, and reporting of whole-body MRI in myeloma and allow response assessment. This consensus proposes a core clinical protocol for whole-body MRI and an extended protocol for advanced assessments. Published under a CC BY 4.0 license.
机译:承认全身MRI在骨髓瘤,多学科,国际和专家小组的患者护理,医学物理学家和血液学家讨论技术绩效标准的全身MRI专业知识 目前可用的成像方法的优点和限制。 在国际骨髓瘤工作组和国家临床卓越研究所在英国的指导下,骨髓瘤响应评估和诊断系统(或MY-RADS)成像建议旨在促进收购,解释和递减的标准化和减少变化 报告骨髓瘤中全身MRI并允许响应评估。 这一共识为全身MRI和高级评估的扩展议定书提出了一种核心临床课程。 在CC下发布4.0许可证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号